Respiri (RSH) Stock Price, News & Analysis

Company Overview

Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company is based in Melbourne, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.19 million shs
• Average Volume: N/A
• Market Capitalization: A$90.15 million
• P/E Ratio: N/A
• Dividend Yield: 6.00%
• Price Target: N/A
• Consensus Rating: N/A

RSH Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Respiri own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Respiri investors own include Province Resources (PRL) and Lake Resources (LKE).

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ASX:RSH
• CIK: N/A
• Web: www.respiri.co
• Phone: 61 3 9602 3366
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): A($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -A$7.13 million
• Net Margins: -1,560.30%
• Pretax Margin: N/A
• Return on Equity: -231.50%
• Return on Assets: -94.22%

Debt

• Debt-to-Equity Ratio: 49.03
• Current Ratio: 1.18
• Quick Ratio: 1.08

Sales & Book Value

• Annual Sales: A$1.04 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 37.00
• Book Value: A$0.00 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 1,290,000,000
• Free Float: N/A
• Market Cap: A$90.15 million
• Optionable: Not Optionable
• Beta: 0.24